RNA
Atrium Therapeutics, Inc.
8.30$
-1.7%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2011 | 2012 | 2013 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -1,590.6% | – | – | – | – | – | |
| – | – | – | – | -9.1% | +7.2% | +71.3% | +117.1% | +51.5% | +32.1% | -88.4% | |
| – | – | – | – | +576.7% | +961.6% | +295.7% | +59.1% | +40.8% | +34.4% | -85.0% | |
| – | – | – | – | +1,616.1% | -39.5% | +282.3% | +54.0% | – | – | – | |
| – | – | – | – | +2,749.9% | -87.8% | +128.9% | +83.9% | +522.7% | -123.8% | – | |
| – | -88.1% | +169.9% | -94.1% | +379.6% | +364.7% | +242.5% | -24.5% | +49.8% | +67.1% | -79.5% | |
| – | – | – | – | +379.6% | +3,212.8% | +959.9% | +130.2% | -31.5% | +556.7% | -99.8% | |
| – | – | – | – | +0.0% | +318.9% | -100.0% | – | – | – | – | |
| – | – | – | – | +44,769.1% | -99.4% | – | – | – | – | – | |
| – | – | – | – | +234.2% | -128.1% | -100.0% | – | – | – | – | |
| – | +5,678.1% | +156.4% | -94.2% | +1,634.7% | +204.9% | -35.2% | +96.3% | -72.9% | +1,170.3% | -96.4% | |
| – | – | – | – | – | +148.3% | -100.4% | – | -878.4% | – | +336.2% | |
| – | – | – | – | – | -1,794.4% | – | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.